[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2001091700A8 - Composition and method for enhancing elasticity of tissue - Google Patents

Composition and method for enhancing elasticity of tissue

Info

Publication number
WO2001091700A8
WO2001091700A8 PCT/US2001/017384 US0117384W WO0191700A8 WO 2001091700 A8 WO2001091700 A8 WO 2001091700A8 US 0117384 W US0117384 W US 0117384W WO 0191700 A8 WO0191700 A8 WO 0191700A8
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
composition
enhancing elasticity
enhancing
elasticity
Prior art date
Application number
PCT/US2001/017384
Other languages
French (fr)
Other versions
WO2001091700A2 (en
Inventor
Thomas F Mitts
Lawrence B Sandberg
Felipe Jimenez Jr
Original Assignee
Connective Tissue Imagineering
Thomas F Mitts
Lawrence B Sandberg
Felipe Jimenez Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Priority to NZ523403A priority Critical patent/NZ523403A/en
Priority to EP01941684A priority patent/EP1392346A4/en
Application filed by Connective Tissue Imagineering, Thomas F Mitts, Lawrence B Sandberg, Felipe Jimenez Jr filed Critical Connective Tissue Imagineering
Priority to AU7501801A priority patent/AU7501801A/en
Priority to CA002415225A priority patent/CA2415225A1/en
Priority to IL15368701A priority patent/IL153687A0/en
Priority to AU2001275018A priority patent/AU2001275018B2/en
Publication of WO2001091700A2 publication Critical patent/WO2001091700A2/en
Priority to NO20030454A priority patent/NO20030454L/en
Publication of WO2001091700A8 publication Critical patent/WO2001091700A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/US2001/017384 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue WO2001091700A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2001275018A AU2001275018B2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
IL15368701A IL153687A0 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
CA002415225A CA2415225A1 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
AU7501801A AU7501801A (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
EP01941684A EP1392346A4 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
NZ523403A NZ523403A (en) 2000-05-30 2001-05-30 Compounds that increase tissue elasticity and turgor which are analogous to portions of elastin
NO20030454A NO20030454L (en) 2000-05-30 2003-01-29 Composition and method of enhancing tissue elasticity

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
US09/580,893 2000-05-30
US09/580,110 2000-05-30
US09/584,001 2000-05-30
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,156 2000-05-30
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents

Publications (2)

Publication Number Publication Date
WO2001091700A2 WO2001091700A2 (en) 2001-12-06
WO2001091700A8 true WO2001091700A8 (en) 2003-11-20

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/017384 WO2001091700A2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue

Country Status (7)

Country Link
EP (1) EP1392346A4 (en)
AU (2) AU7501801A (en)
CA (1) CA2415225A1 (en)
IL (1) IL153687A0 (en)
NO (1) NO20030454L (en)
NZ (1) NZ523403A (en)
WO (1) WO2001091700A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (en) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif USE OF PEPTIDES TO INCREASE CELL ADHESION
KR20050033512A (en) * 2001-10-05 2005-04-12 프로사이트 코포레이션 Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
JP2005511650A (en) * 2001-10-05 2005-04-28 プロサイト コーポレイション Treatment of skin hyperpigmentation
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (en) * 2002-12-20 2004-07-08 Henkel Kgaa Method for the determination of markers of human facial skin
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (en) * 2003-05-12 2007-05-04 Sederma Sa COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIGNS OF SKIN AGING.
EP1765280A1 (en) * 2004-06-28 2007-03-28 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
CN101443031A (en) 2006-05-15 2009-05-27 瓦利奥有限公司 New application of treatment peptides
US8367619B2 (en) 2007-02-16 2013-02-05 Benaroya Research Institute At Virginia Mason Methods for promoting elastogenesis and elastin fiber formation by increasing tropoelastin expression
DK2683393T3 (en) 2011-02-11 2018-07-23 Univ Michigan Regents TRIPEPTIME COMPOSITIONS AND THEIR USE IN TREATING DIABETES
JP5841234B2 (en) 2011-03-31 2016-01-13 ザ プロクター アンド ギャンブルカンパニー Systems, models, and methods for identifying and evaluating skin active agents effective in the treatment of dandruff / seborrheic dermatitis
MX2014014898A (en) 2012-06-06 2015-03-04 Procter & Gamble Systems and methods for identifying cosmetic agents for hair/scalp care compositions.
FR3116273B1 (en) * 2020-11-17 2023-10-27 Sederma Sa Tetrapeptides, compositions comprising them and their cosmetic use
KR102484277B1 (en) * 2021-11-22 2023-01-04 대한켐텍 주식회사 Manufacturing Method Of Raw Material Composition For Improving Skin Beauty

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (en) * 1997-04-11 1998-10-15 Targor Gmbh Metallocene amino acid and peptide complexes
CA2287254A1 (en) * 1997-04-21 1998-10-29 Schering Corporation Mammalian cytokines; related reagents and methods
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
AP2000001882A0 (en) * 1998-11-19 2000-09-30 Connective Tissue Imagineering Cosmetic or dermatological use of 7-hydroxylated steroids alone and /or in combination with elastin derived peptides.
PT2275551E (en) * 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Neisserial antigenic peptides

Also Published As

Publication number Publication date
AU7501801A (en) 2001-12-11
EP1392346A4 (en) 2006-10-25
CA2415225A1 (en) 2001-12-06
NZ523403A (en) 2005-04-29
WO2001091700A2 (en) 2001-12-06
EP1392346A2 (en) 2004-03-03
NO20030454D0 (en) 2003-01-29
NO20030454L (en) 2003-01-29
AU2001275018B2 (en) 2008-04-03
IL153687A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
AU2001249967A1 (en) Composition and methods for tissue preservation
AUPR638101A0 (en) Composition and method for treatment of disease
AU2002241228A1 (en) Method and composition for treatment of skeletal dysplasias
AU2001270943A1 (en) Surgical instrument and method of using the same
AU2001271530A1 (en) Method of hard tissue repair
AU2001233081A1 (en) Composition for treatment of stress
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU5800399A (en) Polish composition and method of use
AU2001274181A1 (en) Composition and method for biocide treatment of surfaces
AU2001286983A1 (en) Method of treatment
AU2001233932A1 (en) Method and composition
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2962400A (en) Cleaner composition and method of use thereof
AU2001288291A1 (en) Paving and sealing composition and method of use
AU2003282593A1 (en) Polyphenolamine composition and method of use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001262177A1 (en) Method of treatment
AU2002239775A1 (en) Chemical-library composition and method
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU2001249194A1 (en) Immunokine composition and method
AUPQ876400A0 (en) Compositions and method of using them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 153687

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001941684

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001275018

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 523403

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2415225

Country of ref document: CA

D17 Declaration under article 17(2)a
WWP Wipo information: published in national office

Ref document number: 2001941684

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWP Wipo information: published in national office

Ref document number: 523403

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 523403

Country of ref document: NZ